PREDICT STUDY FINAL RESULTS: EFFICACY AND SAFETY OF 24-WK REGIMEN OF PEGINTERFERON ALFA-2B PLUS WEIGHT-BASED RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE 1 (G1) WITH LOW VIRAL LOAD WHO ACHIEVE RAPID VIRAL RESPONSE

Авторы
Craxi A. 1 , Zuckerman E. 2 , Koutsounas S. 3 , Ogurtsov P.P. 4 , Chemello L. 5 , Maticic M.B. 6 , Torras X. 7 , Diago M. 8 , Tartaglione M. 9 , Witthoeft T. 10 , Yu X. 11 , Chaudhri E.I. 11 , Pedicone L. 11 , Faruqi R. 11
Conference proceedings
Издательство
WILEY-BLACKWELL
Номер выпуска
4
Язык
English
Статус
Published
Том
50
Год
2009
Организации
  • 1 Univ Palermo, Palermo, Italy
  • 2 Carmel Hosp, Liver Unit, Haifa, Israel
  • 3 1st Hosp IKA PENTELI, Mellisia, Greece
  • 4 Russian Univ People Friendship, Moscow, Russia
  • 5 Univ Padua, Padua, Italy
  • 6 Univ Med Ctr Ljubljana, Dept Infect Dis & Febrile Illnesses, Ljubljana, Slovenia
  • 7 Hosp Santa Creu & Sant Pau, Barcelona, Spain
  • 8 Hosp Gen Valencia, Valencia, Spain
  • 9 Cardarelli Hosp, Naples, Italy
  • 10 Univ Hosp Schleswig Holstein, Lubeck, Germany
  • 11 Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
Цитировать
Поделиться

Другие записи